Patents by Inventor Ke An
Ke An has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12641756Abstract: A data analysis-based energy-saving control method for a precision air conditioner in a cloud computing data center, a medium, and a system, initially trains a Bayesian linear regression model based on historical datasets of heat source data of a cloud server and control quantity data of a precision air conditioner, and is used to predict a temperature difference between temperature sensors in a data center in future time, obtain newly-added training data in real time in a control process, update the Bayesian linear regression model in real time, predict the temperature difference between the sensors in real time, and obtain an optimal control quantity of a combination of a frequency of a discrete compressor and an opening degree of a water valve in real time by using a grid search algorithm to control an actual temperature difference between the sensors in the future.Type: GrantFiled: July 13, 2021Date of Patent: May 26, 2026Assignee: SHANGHAI YOVOLE NETWORKS INC.Inventors: Jiwen Li, Xin Lyu, Ke An, Rong Xu
-
Patent number: 12415799Abstract: A novel indazole compound, a preparation method therefor, and use thereof in the preparation of drugs for treating related diseases. Specifically disclosed are a compound of formula (II) and a pharmaceutically acceptable salt thereof.Type: GrantFiled: June 28, 2021Date of Patent: September 16, 2025Assignee: Zhejiang Yangli Pharmaceutical Technology Co., Ltd.Inventors: Ke An, Na Gao, Guoping Hu, Jian Li, Shuhui Chen, Deheng Sun
-
Patent number: 12410155Abstract: A class of salt forms and crystal forms of a tetrahydrocyclohepta indazole compound and a preparation method therefor. Specifically disclosed is the uses of the salt form and crystal form of the compound of formula (I) in the preparation of a drug for treating related diseases.Type: GrantFiled: December 28, 2022Date of Patent: September 9, 2025Assignee: ZHEJIANG YANGLI PHARMACEUTICAL TECHNOLOGY CO., LTD.Inventors: Ke An, Shuhui Chen
-
Publication number: 20250084068Abstract: A class of salt forms and crystal forms of a tetrahydrocyclohepta indazole compound and a preparation method therefor. Specifically disclosed is the uses of the salt form and crystal form of the compound of formula (I) in the preparation of a drug for treating related diseases.Type: ApplicationFiled: December 28, 2022Publication date: March 13, 2025Inventors: Ke AN, Shuhui CHEN
-
Publication number: 20240033278Abstract: The present application relates to a novel conjugate group linkable to a compound (such as a therapeutic compound), for use in directing the compound to a target in the body. The conjugate group disclosed herein can enable an expression-inhibitory oligonucleotide (such as a RNAi reagent) to target liver cells to regulate gene expression. The conjugate group disclosed herein has a variety of applications when linked to expression-inhibitory oligonucleotides, comprising applications in therapy, diagnosis, target verification, and genome development. A composition comprising the conjugate group disclosed herein can mediate expression of target nucleic acid sequences in liver cells (such as hepatocytes) when linked to expression-inhibitory oligonucleotides, and can be used for treatment of diseases or disorders responding to the gene expression or activity of cells, tissues, or organisms.Type: ApplicationFiled: June 10, 2021Publication date: February 1, 2024Applicant: MEDSHINE DISCOVERY INC.Inventors: Ke AN, Fei SUN, Charles Z. DING, Shuhui CHEN
-
Publication number: 20230371213Abstract: A data analysis-based energy-saving control method for a precision air conditioner in a cloud computing data center, a medium, and a system, initially trains a Bayesian linear regression model based on historical datasets of heat source data of a cloud server and control quantity data of a precision air conditioner, and is used to predict a temperature difference between temperature sensors in a data center in future time, obtain newly-added training data in real time in a control process, update the Bayesian linear regression model in real time, predict the temperature difference between the sensors in real time, and obtain an optimal control quantity of a combination of a frequency of a discrete compressor and an opening degree of a water valve in real time by using a grid search algorithm to control an actual temperature difference between the sensors in the future.Type: ApplicationFiled: July 13, 2021Publication date: November 16, 2023Applicant: SHANGHAI YOVOLE NETWORKS INC.Inventors: Jiwen LI, Xin LYU, Ke AN, Rong XU
-
Patent number: 11768128Abstract: An internal combustion engine for neutron diffraction analysis is provided. The engine includes an elongated piston chamber formed from an aluminum alloy to ensure maximum neutron visibility into the combustion chamber. An elongated piston assembly reciprocates within the elongated piston chamber, the piston assembly including an upper piston joined to a lower piston. The upper piston and the lower piston are hollow, thereby reducing the reciprocating mass and increasing neutron access to the combustion chamber. The upper piston is lubricated with a neutron-transparent fluorocarbon lubricant such as perfluoropolyether (PFPE), while the lower piston and the crankcase are lubricated with hydrocarbon lubricant. The engine enables 3D and time-resolved measurements of strain, stress, and temperature, as well as phase transformation, texture, and microstructure.Type: GrantFiled: June 7, 2022Date of Patent: September 26, 2023Assignee: UT-BATTELLE, LLCInventors: Martin L. Wissink, Christopher L. Wray, Scott J. Curran, Ke An, Matthew J. Frost, Yan Chen
-
Publication number: 20230242507Abstract: A novel indazole compound, a preparation method therefor, and use thereof in the preparation of drugs for treating related diseases. Specifically disclosed are a compound of formula (II) and a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: June 28, 2021Publication date: August 3, 2023Inventors: Ke AN, Na GAO, Guoping HU, Jian LI, Shuhui CHEN, Deheng SUN
-
Publication number: 20230235330Abstract: Provided are a double-stranded siRNA analogue embedded with a ribavirin derivative, a conjugate containing same, and a salt and the use thereof. The provided double-stranded siRNA analogue, the conjugate containing same and the salt thereof can effectively inhibit multiple viral indicators such as hepatitis B virus DNA, pgRNA, S antigen, and E antigen, which provide an effective and feasible method for treating hepatitis B.Type: ApplicationFiled: June 7, 2021Publication date: July 27, 2023Inventors: Ke AN, Fei SUN, Charles Z. DING, Shuhui CHEN
-
Publication number: 20230220386Abstract: Provided is an application of a ribavirin derivative as an oligonucleotide embedded group. Specifically, disclosed is an application of r as a siRNA embedded group. Also provided is an r?-embedded siRNA conjugate, a double-stranded siRNA conjugate, a salt thereof, and an application thereof. The r?-embedded siRNA conjugate and the salt thereof can effectively reduce the S antigen content and E antigen content of the hepatitis B virus, providing an effective, feasible approach for the functional cure of chronic hepatitis B.Type: ApplicationFiled: December 4, 2020Publication date: July 13, 2023Inventors: Ke AN, Fei SUN, Charles Z. DING, Jian LI, Shuhui CHEN
-
Publication number: 20230210882Abstract: The present application relates to a novel conjugate group linkable to a compound (such as a therapeutic compound), for use in directing the compound to a target in the body. The conjugate group disclosed herein can enable an expression-inhibitory oligonucleotide (such as a RNAi reagent) to target liver cells to regulate gene expression. The conjugate group disclosed herein has a variety of applications when linked to expression-inhibitory oligonucleotides, comprising applications in therapy, diagnosis, target verification, and genome development. A composition comprising the conjugate group disclosed herein can mediate expression of target nucleic acid sequences in liver cells (such as hepatocytes) when linked to expression-inhibitory oligonucleotides, and can be used for treatment of diseases or disorders responding to the gene expression or activity of cells, tissues, or organisms.Type: ApplicationFiled: June 10, 2021Publication date: July 6, 2023Applicant: MEDSHINE DISCOVERY INC.Inventors: Ke AN, Fei SUN, Charles Z. DING, Shuhui CHEN
-
Publication number: 20220390326Abstract: An internal combustion engine for neutron diffraction analysis is provided. The engine includes an elongated piston chamber formed from an aluminum alloy to ensure maximum neutron visibility into the combustion chamber. An elongated piston assembly reciprocates within the elongated piston chamber, the piston assembly including an upper piston joined to a lower piston. The upper piston and the lower piston are hollow, thereby reducing the reciprocating mass and increasing neutron access to the combustion chamber. The upper piston is lubricated with a neutron-transparent fluorocarbon lubricant such as perfluoropolyether (PFPE), while the lower piston and the crankcase are lubricated with hydrocarbon lubricant. The engine enables 3D and time-resolved measurements of strain, stress, and temperature, as well as phase transformation, texture, and microstructure.Type: ApplicationFiled: June 7, 2022Publication date: December 8, 2022Inventors: Martin L. Wissink, Christopher L. Wray, Scott J. Curran, Ke An, Matthew J. Frost, Yan Chen
-
Patent number: 8445138Abstract: A lightweight, durable lead-acid battery is disclosed. Alternative electrode materials and configurations are used to reduce weight, to increase material utilization and to extend service life. The electrode can include a current collector having a buffer layer in contact with the current collector and an electrochemically active material in contact with the buffer layer. In one form, the buffer layer includes a carbide, and the current collector includes carbon fibers having the buffer layer. The buffer layer can include a carbide and/or a noble metal selected from of gold, silver, tantalum, platinum, palladium and rhodium. When the electrode is to be used in a lead-acid battery, the electrochemically active material is selected from metallic lead (for a negative electrode) or lead peroxide (for a positive electrode).Type: GrantFiled: July 19, 2011Date of Patent: May 21, 2013Assignee: UT-Battelle LLCInventors: Edgar Lara-Curzio, Ke An, James O. Kiggans, Jr., Nancy J. Dudney, Cristian I. Contescu, Frederick S. Baker, Beth L. Armstrong
-
Publication number: 20110294008Abstract: A lightweight, durable lead-acid battery is disclosed. Alternative electrode materials and configurations are used to reduce weight, to increase material utilization and to extend service life. The electrode can include a current collector having a buffer layer in contact with the current collector and an electrochemically active material in contact with the buffer layer. In one form, the buffer layer includes a carbide, and the current collector includes carbon fibers having the buffer layer. The buffer layer can include a carbide and/or a noble metal selected from of gold, silver, tantalum, platinum, palladium and rhodium. When the electrode is to be used in a lead-acid battery, the electrochemically active material is selected from metallic lead (for a negative electrode) or lead peroxide (for a positive electrode).Type: ApplicationFiled: July 19, 2011Publication date: December 1, 2011Inventors: Edgar Lara-Curzio, Ke An, James O. Kiggans, JR., Nancy J. Dudney, Cristian I. Contescu, Frederick S. Baker, Beth L. Armstrong
-
Patent number: 8017273Abstract: A lightweight, durable lead-acid battery is disclosed. Alternative electrode materials and configurations are used to reduce weight, to increase material utilization and to extend service life. The electrode can include a current collector having a buffer layer in contact with the current collector and an electrochemically active material in contact with the buffer layer. In one form, the buffer layer includes a carbide, and the current collector includes carbon fibers having the buffer layer. The buffer layer can include a carbide and/or a noble metal selected from of gold, silver, tantalum, platinum, palladium and rhodium. When the electrode is to be used in a lead-acid battery, the electrochemically active material is selected from metallic lead (for a negative electrode) or lead peroxide (for a positive electrode).Type: GrantFiled: April 28, 2008Date of Patent: September 13, 2011Assignee: UT-Battelle LLCInventors: Edgar Lara-Curzio, Ke An, James O. Kiggans, Jr., Nancy J. Dudney, Cristian I. Contescu, Frederick S. Baker, Beth L. Armstrong
-
Publication number: 20090269666Abstract: A lightweight, durable lead-acid battery is disclosed. Alternative electrode materials and configurations are used to reduce weight, to increase material utilization and to extend service life. The electrode can include a current collector having a buffer layer in contact with the current collector and an electrochemically active material in contact with the buffer layer. In one form, the buffer layer includes a carbide, and the current collector includes carbon fibers having the buffer layer. The buffer layer can include a carbide and/or a noble metal selected from of gold, silver, tantalum, platinum, palladium and rhodium. When the electrode is to be used in a lead-acid battery, the electrochemically active material is selected from metallic lead (for a negative electrode) or lead peroxide (for a positive electrode).Type: ApplicationFiled: April 28, 2008Publication date: October 29, 2009Inventors: Edgar Lara-Curzio, Ke An, James O. Kiggans, JR., Nancy J. Dudney, Cristian I. Contescu, Frederick S. Baker, Beth L. Armstrong